Shares of Halozyme Therapeutics, Inc. HALO were up 5% on Jan. 8 after the company raised its guidance for 2025. The stock gained another 1.8% in after-hours trading. HALO also maintained its full-year ...

Roche's strategic acquisition of Poseida Pharmaceuticals positions them as a leader in the allogeneic cell therapy market.

The National Agency for Food and Drug Administration and Control (NAFDAC) has issued a public alert about a suspected ...

The National Agency for Food and Drug Administration and Control (NAFDAC) warns the public against counterfeit cancer drugs Phesgo® 600mg ...

Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme" or the "Company") today provided a financial update, reiterating full ...

The National Agency for Food and Drug Administration and Control (NAFDAC) has notified Nigerians, including healthcare ...

The National Agency for Food and Drug Administration and Control (NAFDAC) has issued an urgent alert to healthcare providers ...

NAFDAC, has issued an alert to healthcare professionals and the public regarding a suspected counterfeit batch of drug.

The National Agency for Food and Drug Administration and Control, NAFDAC, has alerted Nigerians, including healthcare ...

The National Agency for Food and Drug Administration and Control (NAFDAC) has warned Nigerians to be wary of counterfeit cancer treatment drugs, Phesgo, in circulation.

NAFDAC has warned of a counterfeit Phesgo 600mg/600mg/10ml cancer drug batch, confirming fake labels, tampering, and an invalid batch number.